| scholarly article | Q13442814 |
| P2093 | author name string | P Hauser | |
| E Bouffet | |||
| S Albrecht | |||
| M Garami | |||
| J Atkinson | |||
| C Hawkins | |||
| K Jacob | |||
| U Tabori | |||
| L Bognar | |||
| N Jabado | |||
| D Serre | |||
| J L Montes | |||
| J-P Farmer | |||
| A Montpetit | |||
| C Sollier | |||
| D Faury | |||
| E Sader | |||
| Z Hanzely | |||
| P2860 | cites work | How cells switch HIPK2 on and off | Q24310662 |
| The 2007 WHO classification of tumours of the central nervous system | Q24685772 | ||
| Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer | Q27824825 | ||
| Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF | Q28251989 | ||
| Sam68 association with p120GAP in CD4+ T cells is dependent on CD4 molecule expression | Q28282892 | ||
| Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas | Q28299301 | ||
| PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data | Q29614933 | ||
| Gene expression profiling from formalin-fixed paraffin-embedded tumors of pediatric glioblastoma | Q33304622 | ||
| Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene | Q33772206 | ||
| The WHO classification of tumors of the nervous system | Q33845646 | ||
| High frequency of BRAF mutations in nevi | Q34160519 | ||
| Radial glia cells are candidate stem cells of ependymoma | Q34459796 | ||
| A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene | Q34651283 | ||
| The influence of central review on outcome associations in childhood malignant gliomas: results from the CCG-945 experience | Q35158360 | ||
| Comparative genomic hybridization in central and peripheral nervous system tumors of childhood and adolescence | Q35805725 | ||
| GATA6 is an astrocytoma tumor suppressor gene identified by gene trapping of mouse glioma model | Q35808904 | ||
| Preliminary observations on genetic alterations in pilocytic astrocytomas associated with neurofibromatosis 1 | Q35894982 | ||
| BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas | Q36532504 | ||
| Constitutive activation of Raf-1 induces glioma formation in mice | Q36640215 | ||
| Neurofibromatosis 1 and 2. | Q36862377 | ||
| Mouse models for BRAF-induced cancers | Q36979850 | ||
| The origins of medulloblastoma subtypes | Q37014819 | ||
| High-resolution, dual-platform aCGH analysis reveals frequent HIPK2 amplification and increased expression in pilocytic astrocytomas. | Q39992412 | ||
| Secreted protein acidic, rich in cysteine (SPARC), mediates cellular survival of gliomas through AKT activation | Q40506981 | ||
| Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma | Q41888346 | ||
| A negative feedback signaling network underlies oncogene-induced senescence | Q43116108 | ||
| Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma | Q44739121 | ||
| Outcome analysis of childhood low-grade astrocytomas | Q46350472 | ||
| Oncogenic Ras and Akt Signaling Contribute to Glioblastoma Formation by Differential Recruitment of Existing mRNAs to Polysomes | Q47421825 | ||
| Absence of p53 gene mutations in a tumor panel representative of pilocytic astrocytoma diversity using a p53 functional assay | Q47975834 | ||
| Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas. | Q47992753 | ||
| RAS/RAF pathway activation in gliomas: the result of copy number gains rather than activating mutations | Q48127930 | ||
| Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors. | Q48221611 | ||
| Clinical and molecular characteristics of malignant transformation of low-grade glioma in children | Q48269415 | ||
| Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin | Q48282147 | ||
| Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital | Q48651367 | ||
| Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas | Q49150021 | ||
| Genome-wide allelic imbalance analysis of pediatric gliomas by single nucleotide polymorphic allele array. | Q54568803 | ||
| Intratumoral genetic heterogeneity in pilocytic astrocytomas revealed by CGH-analysis of microdissected tumor cells and FISH on tumor tissue sections. | Q55470679 | ||
| When do children with optic pathway tumours need treatment? An oncological perspective in 106 patients treated in a single centre. | Q55475095 | ||
| Nonrandom chromosomal gains in pilocytic astrocytomas of childhood. | Q55480493 | ||
| RAF/RAS oncogenes and mismatch-repair status | Q57281056 | ||
| BRAF and RAS mutations in human lung cancer and melanoma | Q78598197 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 722-733 | |
| P577 | publication date | 2009-07-14 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours | |
| P478 | volume | 101 |
| Q33610906 | A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma |
| Q35815306 | A pilot study using carboplatin, vincristine, and temozolomide in children with progressive/symptomatic low-grade glioma: a Children's Oncology Group study† |
| Q34755317 | An activated mutant BRAF kinase domain is sufficient to induce pilocytic astrocytoma in mice |
| Q39788891 | Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma |
| Q54376904 | Analysis of KIAA1549-BRAF fusion gene expression and IDH1/IDH2 mutations in low grade pediatric astrocytomas. |
| Q55463150 | Analysis of KIAA1549-BRAF fusion status in a case of rosette-forming glioneuronal tumor of the fourth ventricle (RGNT). |
| Q36525778 | Analysis of the BRAF(V600E) Mutation in Central Nervous System Tumors. |
| Q36009738 | BRAF Fusion Analysis in Pilocytic Astrocytomas: KIAA1549-BRAF 15-9 Fusions Are More Frequent in the Midline Than Within the Cerebellum |
| Q33862879 | BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model. |
| Q43697152 | BRAF alterations in pediatric low grade gliomas and mixed neuronal-glial tumors |
| Q36239628 | BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549:BRAF fusion variants. |
| Q38919639 | BRAF and MEK inhibitors in pediatric glioma: new therapeutic strategies, new toxicities. |
| Q36195173 | BRAF duplications and MAPK pathway activation are frequent in gliomas of the optic nerve proper |
| Q42739240 | BRAF-V600E mutation in pediatric and adult glioblastoma. |
| Q39556985 | Biomarkers classification and therapeutic decision-making for malignant gliomas |
| Q37515982 | Challenges in Drug Discovery for Neurofibromatosis Type 1-Associated Low-Grade Glioma |
| Q38083799 | Chromatin remodeling defects in pediatric and young adult glioblastoma: a tale of a variant histone 3 tail |
| Q34810518 | Chromosome band 7q34 deletions resulting in KIAA1549-BRAF and FAM131B-BRAF fusions in pediatric low-grade Gliomas |
| Q48138393 | Clinical Application of Whole Genome Array Improves the Diagnosis of Pediatric Brain Tumors |
| Q37255579 | Conditional KIAA1549:BRAF mice reveal brain region- and cell type-specific effects. |
| Q38962187 | Conventional chemotherapy and perspectives for molecular-based oncological treatment in pediatric hemispheric low-grade gliomas |
| Q38382607 | Current Understanding of BRAF Alterations in Diagnosis, Prognosis, and Therapeutic Targeting in Pediatric Low-Grade Gliomas |
| Q54376974 | Desmoplastic non-infantile astrocytic tumor with BRAF V600E mutation. |
| Q38461565 | Diagnostic, prognostic and predictive relevance of molecular markers in gliomas |
| Q34286305 | Differences in molecular genetics between pediatric and adult malignant astrocytomas: age matters. |
| Q38781649 | Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation. |
| Q26864920 | Epigenetic dysregulation: a novel pathway of oncogenesis in pediatric brain tumors |
| Q47940873 | Epithelioid/rhabdoid glioblastoma: a highly aggressive subtype of glioblastoma |
| Q37025863 | Exploiting molecular biology for diagnosis and targeted management of pediatric low-grade gliomas |
| Q36288263 | Expression profiles of 151 pediatric low-grade gliomas reveal molecular differences associated with location and histological subtype |
| Q34625129 | Extracellular vesicles as prospective carriers of oncogenic protein signatures in adult and paediatric brain tumours |
| Q48525606 | Frequent BRAF gain in low-grade diffuse gliomas with 1p/19q loss |
| Q45345277 | Functional characterization of a BRAF insertion mutant associated with pilocytic astrocytoma |
| Q48523422 | Genetic alterations related to BRAF-FGFR genes and dysregulated MAPK/ERK/mTOR signaling in adult pilocytic astrocytoma |
| Q38467680 | Genetic changes observed in a case of adult pilocytic astrocytoma revealed by array CGH analysis |
| Q84475591 | Genomic aberrations in pediatric gliomas and embryonal tumors |
| Q47326645 | Homeodomain interacting protein kinase promotes tumorigenesis and metastatic cell behavior |
| Q33957184 | Identification of transcriptional regulatory networks specific to pilocytic astrocytoma. |
| Q26820289 | In vivo models of brain tumors: roles of genetically engineered mouse models in understanding tumor biology and use in preclinical studies |
| Q42066665 | Innate neural stem cell heterogeneity determines the patterning of glioma formation in children |
| Q59799266 | KIAA1549-BRAF Expression Establishes a Permissive Tumor Microenvironment Through NFκB-Mediated CCL2 Production |
| Q38002123 | Long-term epilepsy-associated tumors |
| Q38569310 | Low Grade Gliomas in Children. |
| Q27006028 | MAPK pathway activation in pilocytic astrocytoma |
| Q39823988 | MAPK pathway activation through BRAF gene fusion in pilocytic astrocytomas; a novel oncogenic fusion gene with diagnostic, prognostic, and therapeutic potential |
| Q50215075 | Marked functional recovery and imaging response of refractory optic pathway glioma to BRAFV600E inhibitor therapy: a report of two cases |
| Q36500392 | MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2. |
| Q48023007 | Molecular Basis of Pediatric Brain Tumors |
| Q92628156 | Molecular Biomarkers of Brain and Spinal Cord Astrocytomas |
| Q28383205 | Molecular Markers in Low-Grade Glioma-Toward Tumor Reclassification |
| Q38070437 | Molecular diagnostics in paediatric glial tumours |
| Q38268366 | Molecular insights into pediatric brain tumors have the potential to transform therapy |
| Q36344704 | Molecular markers in pediatric neuro-oncology |
| Q38050966 | Molecular markers of glioma: an update on recent progress and perspectives |
| Q38539422 | Molecular profiling of gliomas: potential therapeutic implications. |
| Q47869458 | Multiplex Detection of Pediatric Low-Grade Glioma Signature Fusion Transcripts and Duplications Using the NanoString nCounter System |
| Q45392719 | Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells |
| Q39167472 | New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M. |
| Q36544705 | Non-random aneuploidy specifies subgroups of pilocytic astrocytoma and correlates with older age. |
| Q35882807 | Novel BRAF Alteration in a Sporadic Pilocytic Astrocytoma |
| Q42812964 | Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma |
| Q48231129 | Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution |
| Q36157714 | PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma |
| Q27026123 | Pathological and molecular advances in pediatric low-grade astrocytoma |
| Q35754390 | Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape |
| Q38363549 | Pediatric brainstem gliomas: new understanding leads to potential new treatments for two very different tumors. |
| Q36464991 | Pediatric glioma-associated KIAA1549:BRAF expression regulates neuroglial cell growth in a cell type-specific and mTOR-dependent manner. |
| Q38125816 | Pediatric high-grade astrocytomas: a distinct neuro-oncological paradigm |
| Q90275490 | Pediatric low-grade glioma in the era of molecular diagnostics |
| Q33847771 | Pediatric low-grade gliomas: how modern biology reshapes the clinical field |
| Q28286218 | Pilocytic astrocytoma: a disease with evolving molecular heterogeneity |
| Q38384754 | Pilocytic astrocytoma: pathology, molecular mechanisms and markers. |
| Q50965411 | Pilocytic astrocytomas of the optic nerve and their relation to pilocytic astrocytomas elsewhere in the central nervous system |
| Q38203283 | Prognostic and predictive biomarkers in adult and pediatric gliomas: toward personalized treatment |
| Q41909818 | Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent. |
| Q37950470 | Review: low-grade gliomas as neurodevelopmental disorders: insights from mouse models of neurofibromatosis-1. |
| Q44620603 | SgD-CNV, a database for common and rare copy number variants in three Asian populations |
| Q55123347 | Spontaneous Malignant Transformation of a Pilocytic Astrocytoma of Cerebellum: Case Report. |
| Q48686457 | Spontaneous modifications of contrast enhancement in childhood non-cerebellar pilocytic astrocytomas |
| Q38194055 | Targeted therapy in pediatric low-grade glioma |
| Q37780775 | Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas |
| Q92152749 | The crystal structure of the protein kinase HIPK2 reveals a unique architecture of its CMGC-insert region |
| Q55461604 | The diagnostic role and clinical relevance of determination of BRAF status in brain tumors. |
| Q37738138 | The genetics of pediatric brain tumors |
| Q38102568 | The molecular and cell biology of pediatric low-grade gliomas. |
| Q27010414 | The molecular biology of WHO grade I astrocytomas |
| Q59335097 | V600E Inhibitor (Vemurafenib) for V600E Mutated Low Grade Gliomas |
| Q27012684 | Will kinase inhibitors make it as glioblastoma drugs? |
Search more.